ALLMedicine™ Hyperbilirubinemia Center

Mar 26th, 2023 - Extracorporeal blood purification (EBP) is increasingly applied for bilirubin removal in critical care setting. We retrospectively reviewed the clinical features of children aged 1 month to 18 years old who received EBP for hyperbilirubinemia and ...

Mar 25th, 2023 - We analyze phototherapy rates after implementation of a Hyperbilirubinemia Clinical Pathway (HCP), which placed full-term ABOi DAT negative newborns on the low risk phototherapy nomogram, rather than medium risk, as previously done. A chart review...

Mar 22nd, 2023 - Practice Essentials Hereditary spherocytosis (HS) is a familial hemolytic disorder associated with a variety of mutations that lead to defects in red blood cell (RBC) membrane proteins. [1, 2] It is also one of the most common causes of hemolytic ...

Mar 22nd, 2023 - Practice Essentials Hereditary spherocytosis (HS) is a familial hemolytic disorder associated with a variety of mutations that lead to defects in red blood cell (RBC) membrane proteins. [1, 2] It is also one of the most common causes of hemolytic ...

Mar 22nd, 2023 - Practice Essentials Hereditary spherocytosis (HS) is a familial hemolytic disorder associated with a variety of mutations that lead to defects in red blood cell (RBC) membrane proteins.[1, 2] It is also one of the most common causes of hemolytic a...

Sep 30th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...

Sep 29th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...

Feb 9th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,

Feb 13th, 2023 - Gilbert syndrome is a mild genetic liver disorder in which the body cannot properly process bilirubin, a yellowish waste product that is formed when old or worn out red blood cells are broken down (hemolysis). It is inherited as an autosomal reces...

Feb 6th, 2023 - The digestive tract, particularly the liver, has recently been reported to be affected by SARS-CoV-2. Although abnormal liver enzymes were regularly described as an extra-pulmonary clinical feature, and almost one half of patients experienced grad...

Jan 17th, 2023 - PROCEDURES DURING PREGNANCY During the first antenatal care visit the mother will have a gestational dating ultrasound to determine the accurate gestational age. During all antenatal care visits information about the mother will be collected as pa...

Jan 12th, 2023 - Gestational diabetes mellitus (GDM) affects 5-8% of pregnant women, many of whom will require treatment beyond diet and exercise. Despite this high prevalence, there is no consensus regarding the glycemic threshold for conversion from diet to medi...

Dec 14th, 2022 - Cerebral palsy (CP) is a group of neuromuscular disorders affecting the development of movement and posture, causing activity limitations. Disturbances to the development of the infant brain may occur early either in utero, during birth or in the ...

Nov 8th, 2022 - Regorafenib (Stivarga) plus ipilimumab (Yervoy) and nivolumab (Opdivo) led to encouraging survival and responses in approximately half of patients with microsatellite stable (MSS), non–liver metastatic colorectal cancer (mCRC) who progressed on pr...

Aug 8th, 2022 - Raising phototherapy thresholds and revising risk assessment are among the key changes in the American Academy of Pediatrics' updated guidelines for managing hyperbilirubinemia in infants 35 weeks' gestation and older. "More than 80% of newborn in...

Aug 5th, 2022 - Raising phototherapy thresholds and revising risk assessment are among the key changes in the American Academy of Pediatrics’ updated guidelines for managing hyperbilirubinemia in infants 35 weeks’ gestation and older. “More than 80% of newborn in.

Aug 4th, 2022 - Combining transarterial chemoembolization (TACE) with lenvatinib (Lenvima) as first-line treatment for advanced hepatocellular carcinoma (HCC) prolonged survival compared with lenvatinib alone, the phase III LAUNCH trial showed. Median overall sur...

Jun 23rd, 2022 - Richard Stone, MD: Let’s move on to the next part of this case. We gave him the 7+3 [chemotherapy regimen]. He had some mucositis and febrile neutropenia, but he got through it. He went into remission. He was still MRD [minimal residual disease] p...